Benzinga··PrnewswireCell Therapies Graduate to Mass Production as Market Eyes $8.2B Prize
Cell therapy companies achieve major manufacturing and clinical milestones, positioning sector for explosive growth as global market targets $8.2 billion by 2026.
MESOFATEFBLGLGVNbiotechclinical trials